Why the study?
Does amlodipine or atenolol reduce blood pressure in patients with mild to moderate hypertension compared to placebo?
Does amlodipine or atenolol reduce blood pressure in patients with mild to moderate hypertension compared to placebo?
Once-daily dosing with either amlodipine or atenolol significantly reduces blood pressure and is well tolerated in patients with mild to moderate hypertension.
Answers are grounded in this paper and cite their sources.
Supports once-daily amlodipine or atenolol in mild-moderate hypertension; confirms sustained 24-hour efficacy in this RCT.
Once-daily administration of amlodipine, a long-acting dihydropyridine calcium-channel blocker, and atenolol, a cardioselective beta-adrenoceptor blocking agent, were compared in patients with mild to moderate hypertension in a multicenter placebo-controlled trial. The starting dose of amlodipine was 2.5 mg, with upward adjustment to 5.0 mg and 10.0 mg at 2-weekly intervals; atenolol was started at 50 mg and titrated to 100 mg after 4 weeks. After 8 weeks of treatment, amlodipine and atenolol both reduced blood pressure to a statistically and clinically significant extent at 24 h postdose, and with a small trough-peak (i.e., 24 h to 8 h postdose) difference. Unlike atenolol, amlodipine had no effects on heart rate. The incidence of side effects was low. There were no clinically significant changes in serum lipids with either drug. It is concluded that once-daily dosing with either amlodipine or atenolol significantly reduces blood pressures. Both amlodipine and atenolol were well tolerated.
No takes yet. Share an insight, caveat, or question.
Bruijn et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: